Gilead Prices $2 Billion of Senior Unsecured Notes

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/24/2026

1. RNG
2. DECK
3. WDC
4. BYD
5. SPOT
6. WCN
7. BMY
8. TSCO
9. BE
10. SPY

Go back to Gilead Prices $2 Billion of Senior Unsecured Notes

Gilead Sciences (GILD) shares oversold argues BofA

September 8, 2023 8:54 AM EDT

BofA analyst Geoff Meacham upgraded shares of Gilead Sciences (NASDAQ: GILD) to Buy from Neutral, with a price target of $95, up from $88 per share, in a note to clients on Friday.

The analyst told investors that the pharmaceutical company's HIV drug upside remains... More